| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 186.729 | 324.976 | 490.990 | 550.840 |
| Total Income - EUR | - | - | - | - | - | 13.438 | 186.729 | 324.976 | 490.990 | 567.774 |
| Total Expenses - EUR | - | - | - | - | - | 12.315 | 169.991 | 250.355 | 400.604 | 531.204 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.123 | 16.738 | 74.620 | 90.386 | 36.571 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.123 | 15.161 | 71.512 | 85.695 | 21.746 |
| Employees | - | - | - | - | - | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Tulipfarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 13.455 | 13.156 | 13.197 | 119.934 | 102.267 |
| Current Assets | - | - | - | - | - | 26.609 | 83.966 | 129.790 | 247.178 | 259.972 |
| Inventories | - | - | - | - | - | 1.942 | 50.452 | 108.746 | 167.218 | 189.697 |
| Receivables | - | - | - | - | - | 9.545 | 21.849 | 17.180 | 74.193 | 55.947 |
| Cash | - | - | - | - | - | 15.121 | 11.665 | 3.864 | 5.766 | 14.328 |
| Shareholders Funds | - | - | - | - | - | 177 | 15.374 | 86.934 | 172.365 | 193.148 |
| Social Capital | - | - | - | - | - | 0 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 39.886 | 81.748 | 56.053 | 194.746 | 169.092 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Tulipfarm S.r.l.